FDA restricts patient access to rosiglitazone
The U.S. Food and Drug Administration (FDA) has added new restrictions on how rosiglitazone-containing medicines (Avandia, Avandamet, Avandaryl): Healthcare providers must enroll in a…
News
FDA permits marketing of dengue fever test
The U.S. Food and Drug Administration is allowing marketing of the first test to help diagnose people with signs and symptoms of dengue fever.…
FDA warns companies to stop MRSA claims
The U.S. Food and Drug Administration has issued four warning letters to companies selling over-the-counter drug products, including hand sanitizers, telling them to stop…
FDA approves contrast agent for CNS MRI scans
The U.S. Food and Drug Administration has approved Gadavist (gadobutrol), a contrast agent for use in patients undergoing magnetic resonance imaging (MRI) of the…
FDA approves new treatment for metastatic melanoma
The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.
FDA approves new drug for COPD
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more…
FDA approves new drug for lupus
The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus in 1955.…
FDA warning for terbutaline in preterm labor
The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in pregnant women…
FDA approves drug to reduce risk of preterm birth
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with…
FDA looks to improve medical device review process
The U.S. Food and Drug Administration plans to implement changes in 2011 designed to improve review of medical devices. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm240418.htm.
FDA approves head lice treatment
The U.S. Food and Drug Administration has approved Natroba (spinosad) Topical Suspension 0.9% for the treatment of head lice in patients 4 years and…
FDA advises women with breast impants
The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic large cell…
FDA restricts patient access to rosiglitazone
The U.S. Food and Drug Administration (FDA) has added new restrictions on how rosiglitazone-containing medicines (Avandia, Avandamet, Avandaryl): Healthcare providers must enroll…
FDA permits marketing of dengue fever test
The U.S. Food and Drug Administration is allowing marketing of the first test to help diagnose people with signs and symptoms of…
FDA warns companies to stop MRSA claims
The U.S. Food and Drug Administration has issued four warning letters to companies selling over-the-counter drug products, including hand sanitizers, telling them…
FDA approves contrast agent for CNS MRI scans
The U.S. Food and Drug Administration has approved Gadavist (gadobutrol), a contrast agent for use in patients undergoing magnetic resonance imaging (MRI)…
FDA approves new treatment for metastatic melanoma
The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.
FDA approves new drug for COPD
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD).…
FDA approves new drug for lupus
The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus…
FDA warning for terbutaline in preterm labor
The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in…
FDA approves drug to reduce risk of preterm birth
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant…
FDA looks to improve medical device review process
The U.S. Food and Drug Administration plans to implement changes in 2011 designed to improve review of medical devices. Read more at…
FDA approves head lice treatment
The U.S. Food and Drug Administration has approved Natroba (spinosad) Topical Suspension 0.9% for the treatment of head lice in patients 4…
FDA advises women with breast impants
The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.